Why Rivian Is Poised to Soar. Hint: It's Not All R2 Hype.
Rivian's investor focus is largely on the R2 launch and ramp-up, but don't overlook its staggering margins in software and services that are helping offset early R2 launch costs.
Market narrative
Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.
Rivian's investor focus is largely on the R2 launch and ramp-up, but don't overlook its staggering margins in software and services that are helping offset early R2 launch costs.
Stocks
biote NASDAQ: BTMD reported lower second-quarter revenue and a net loss as a voluntary recall of certain hormone pellets supplied by Asteria Health disrupted procedure volumes, while management said supply conditions have since normalized and should support sequential improvement in the second half of 2026.
Beyond Meat NASDAQ: BYND reported second-quarter 2026 revenue above its guidance range as international retail growth partially offset continued weakness in U.S. channels and international food service. Management said the company is pursuing a turnaround centered on expanding in Europe and Canada, entering adjacent nutrition categories, and improving operating efficiency.
Caris Life Sciences NASDAQ: CAI reported record clinical volume and raised its full-year revenue outlook after second-quarter revenue increased 45% from a year earlier, driven by growth in molecular profiling services, higher average selling prices and an expanding commercial organization.
Netlist OTCMKTS: NLST announced a five-year strategic alliance with Samsung covering a patent portfolio cross-license, memory product supply, technology cooperation and Samsung's purchase of Netlist shares.
BOGOTÁ, Colombia, Aug. 5, 2026 /PRNewswire/ -- Ecopetrol S.A. ("Ecopetrol" or the "Company") (BVC: ECOPETROL; NYSE: EC) announces that, on August 5, 2026, its Brazilian subsidiary, Ecopetrol Investimentos do Brasil Ltda.
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Humacyte, Inc. (HUMA) concluded the recent trading session at $0.73, signifying a +2.33% move from its prior day's close.
The headline numbers for Sight Sciences (SGHT) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
In the most recent trading session, Camtek (CAMT) closed at $147.6, indicating a -2.65% shift from the previous trading day.
The headline numbers for McKesson (MCK) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Trip.com (TCOM) concluded the recent trading session at $45.96, signifying a -1.88% move from its prior day's close.
In the latest trading session, HP (HPQ) closed at $28.52, marking a -1.04% move from the previous day.
The headline numbers for Solventum (SOLV) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Although the revenue and EPS for Albemarle (ALB) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Kroger (KR) closed at $56.68 in the latest trading session, marking a -1.92% move from the prior day.
The headline numbers for Amdocs (DOX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
The headline numbers for Mirum Pharmaceuticals (MIRM) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Although the revenue and EPS for Corpay (CPAY) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
The headline numbers for Etsy (ETSY) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.